mazindol has been researched along with 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benmansour, S; Bonnet, JJ; Costentin, J; Cubeddu, LX; Parker, EM | 1 |
| Benmansour, S; Bonnet, JJ; Costentin, J; Protais, P | 1 |
| Bonnet, JJ; Costentin, J; Héron, C | 1 |
| Boulay, D; Costentin, J; Duterte-Boucher, D; Leroux-Nicollet, I; Naudon, L | 1 |
4 other study(ies) available for mazindol and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine
| Article | Year |
|---|---|
Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
Topics: Animals; Binding, Competitive; Corpus Striatum; Dopamine; Dopamine Antagonists; Indoles; Male; Mazindol; Neurons; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Substrate Specificity; Thermodynamics | 1990 |
Sodium independence of the binding of [3H]GBR 12783 and other dopamine uptake inhibitors to the dopamine uptake complex.
Topics: Animals; Binding Sites; Corpus Striatum; Dopamine; Mazindol; Nomifensine; Piperazines; Rats; Sodium | 1987 |
Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Topics: Amphetamine; Animals; Binding Sites; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Ethylmaleimide; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Neurons; Nomifensine; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley | 1994 |
Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
Topics: Animals; Autoradiography; Binding, Competitive; Carrier Proteins; Cocaine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Locomotion; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley | 1996 |